Lobbying client
VIRTUS PHARMACEUTICALS LLC
Generic Pharmaceutical Company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
18
Filed by
2
Reported in-house
—
Reported by firms
$210,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2016 to 2019
Filings
7 filings for 2016, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2016
|
MEHLMAN CONSULTING, INC. | $10,000 reported |
|
4th Quarter - Termination 4th Quarter 2016
|
RED+BLUE STRATEGIES | $40,000 reported |
|
4th Quarter - Reportreplaced 4th Quarter 2016
|
RED+BLUE STRATEGIES | $40,000 reported |
|
Registration - Amendment 4th Quarter 2016
|
RED+BLUE STRATEGIES | — reported |
|
3rd Quarter - Report 3rd Quarter 2016
|
MEHLMAN CONSULTING, INC. | $30,000 reported |
|
Registration 4th Quarter 2016
|
RED+BLUE STRATEGIES | — reported |
|
Registration 3rd Quarter 2016
|
MEHLMAN CONSULTING, INC. | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| MEHLMAN CONSULTING, INC. | 11 | $170,000 |
| RED+BLUE STRATEGIES | 1 | $40,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 11 |
| Health Issues | HCR | 10 |
| Budget/Appropriations | BUD | 9 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.